This inventor holds 3 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1995-1996.
Company Filing History:
Years Active: 1995-1996
Title: Wolfgang Roeben: Innovator in Antiretroviral Agents
Introduction
Wolfgang Roeben is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral agents. With a total of 3 patents, his work has had a meaningful impact on medical science.
Latest Patents
Roeben's latest patents include innovative compounds that serve as inhibitors of reverse transcriptase. The first patent, titled "6-thiono-5,6-dihydro-dibenz[B,E]azepin-11-one-11-oximes," relates to the preparation and use of 6-thiono-dibenz[b,e]azepines as antiretroviral agents. The second patent, "5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes," also focuses on similar compounds and their processes for preparation, emphasizing their role in combating viral infections.
Career Highlights
Wolfgang Roeben is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to explore and develop groundbreaking solutions in the field of medicine. His innovative approach has positioned him as a key figure in the research and development of effective treatments.
Collaborations
Throughout his career, Roeben has collaborated with esteemed colleagues, including Hanno Wild and Arnold Paessens. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their research endeavors.
Conclusion
Wolfgang Roeben's contributions to the field of pharmaceuticals, particularly in the development of antiretroviral agents, highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.